Evidence map›Paper›PMID 39701897›Full record

ReviewInfectious disease clinics of North America2025

Histoplasmosis.

Emily M Eichenberger, Jessica S Little, John W Baddley

Abstract readReview
In one paragraph

Review in Infectious disease clinics of North America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Usefulness of Serum as a Non-Invasive Sample for the Detection ofJournal of fungi (Basel, Switzerland) · 2025
    Article
  17. Disseminated histoplasmosis with bone marrow infiltration in a newly diagnosed HIV patient.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Emily M EichenbergerDivision of Infectious Disease, Department of Medicine, Emory School of Medicine, Atlanta, GA, USA. Electronic address: Emily.m.eichenberger@emory.edu.
Jessica S LittleDivision of Infectious Disease, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, PBB-A4, Boston, MA 02115, USA; Division of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
John W BaddleyDivision of Infectious Disease, Department of Medicine, Johns Hopkins University School of Medicine, Boston, MA, USA; Division of Infectious Diseases, Transplant and Oncology Infectious Diseases, The Johns Hopkins University School of Medicine, 725 North Wolfe Street, Baltimore, MD 21205, USA.

Funding

Immune biomarkers to predict outcomes in solid organ transplant patients with bloodstream infectionsK23AI175676 · NIAID · EMORY UNIVERSITY · PI Emily M. Eichenberger · 2024 to 2026
$589k
NIAID NIH HHS K23 AI175676
6 · The paper itself

Abstract

This review provides an update of histoplasmosis, covering the changing epidemiology, pathogenesis, disease manifestations, diagnostic strategies, and management considerations for immunocompetent and immunocompromised populations.

Indexed as

HistoplasmaHistoplasmosisAntifungal AgentsHumansImmunocompromised HostAntifungal AgentsDimorphic fungiEndemic mycosisHistoplasma capsulatumHistoplasmosisItraconazole

Identifiers

PMID39701897
PMCPMC11786977

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.